Skip to content
LexBuild

Importer of Controlled Substances Application: Organic Standards Solutions International, LLC

---
identifier: "/us/fr/2024-28717"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Importer of Controlled Substances Application: Organic Standards Solutions International, LLC"
title_number: 0
title_name: "Federal Register"
section_number: "2024-28717"
section_name: "Importer of Controlled Substances Application: Organic Standards Solutions International, LLC"
positive_law: false
currency: "2024-12-06"
last_updated: "2024-12-06"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "2024-28717"
document_type: "notice"
publication_date: "2024-12-06"
agencies:
  - "Justice Department"
  - "Drug Enforcement Administration"
fr_citation: "89 FR 97070"
fr_volume: 89
docket_ids:
  - "Docket No. DEA-1465"
comments_close_date: "2025-01-06"
fr_action: "Notice of application."
---

#  Importer of Controlled Substances Application: Organic Standards Solutions International, LLC

**AGENCY:**

Drug Enforcement Administration, Justice.

**ACTION:**

Notice of application.

**SUMMARY:**

Organic Standards Solutions International, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to *Supplementary Information* listed below for further drug information.

**DATES:**

Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before January 6, 2025. Such persons may also file a written request for a hearing on the application on or before January 6, 2025.

**ADDRESSES:**

The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to *https://www.regulations.gov* and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on *https://www.regulations.gov.* If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152.

**SUPPLEMENTARY INFORMATION:**

In accordance with 21 CFR 1301.34(a), this is notice that on November 6, 2024, Organic Standards Solutions International, LLC, 7290 Investment Drive, Unit B, North Charleston, South  Carolina 29418-8305, applied to be registered as an importer of the following basic class(es) of controlled substance(s):

| Controlled substance | Drug | Schedule |
| --- | --- | --- |
| Marihuana Extract | 7350 | I |
| Marihuana | 7360 | I |
| Tetrahydrocannabinols | 7370 | I |
| Psilocybin | 7437 | I |
| Psilocyn | 7438 | I |

The company plans to import the listed controlled substances to produce analytical reference standards for sale and distribution to its customers. Drug codes 7350 (Marihuana Extract) and 7360 (Marihuana) will be used for the manufacture of cannabidiol only. In reference to drug code 7370 (Tetrahydrocannabinols) the company plans to import a synthetic version of this controlled substance. No other activities for these drug codes are authorized for this registration.

Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale.

Matthew Strait,

Deputy Assistant Administrator.